Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival
Crossref DOI link: https://doi.org/10.1038/bmt.2016.136
Published Online: 2016-05-16
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sweiss, K
Patel, S
Culos, K
Oh, A
Rondelli, D
Patel, P
Text and Data Mining valid from 2016-05-16
Version of Record valid from 2016-05-16
Article History
Received: 19 January 2016
Revised: 24 March 2016
Accepted: 7 April 2016
First Online: 16 May 2016
Competing interests
: The authors declare no conflict of interest.